Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics First Quarter 2025 Financial Results Conference Call and Webcast.
Amicus Therapeutics Inc. (FOLD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 187,897 | $1,533,240 | 0.01% | |
| 2. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% | |
| 3. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.49 | 1,500 | Director | 65,082 | 2021-11-01 | Filing | |
| $9.56 | 1,500 | Director | 63,582 | 2021-10-01 | Filing | |
| $11.41 | 1,500 | Director | 62,082 | 2021-09-01 | Filing | |
| $9.28 | 1,500 | Director | 60,582 | 2021-08-02 | Filing | |
| $9.24 | 1,500 | Director | 47,467 | 2021-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.00 | 400 | 1,150,657 | 2025-02-19 | Filing | ||
| $10.02 | 7,500 | 886,654 | 2024-12-02 | Filing | ||
| $12.50 | 7,901 | 886,654 | 2024-11-06 | Filing | ||
| $11.46 | 7,500 | 886,654 | 2024-11-01 | Filing | ||
| $10.60 | 7,500 | 886,654 | 2024-10-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,823,772 | $227,041,980 | 0% | |
| 2. | 3,276,371 | $26,735,187 | 0.01% | |
| 3. | 2,010,104 | $16,402,449 | 0.96% | |
| 4. | 1,628,213 | $13,718,553 | 0.02% | |
| 5. | 978,313 | $7,983,033 | 0% |
News See All
11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
10 Best Low Priced Growth Stocks To Invest In
Low priced stocks usually fall under the small to mid-cap size category.
10 Best Low Cost Stocks to Buy According to Billionaires
Markets are wobbling, and panic is becoming the headline. At times when stocks are tumbling, headlines are filled with forecasts that cause anxiety for investors. But it's not new.
12 Best Nasdaq Stocks Under $20 to Buy Now
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
12 Stocks Under $10 With High Upside Potential
Small-cap stocks in the U.S. have suffered as the broader market is under pressure due to the ongoing tariff policy transition.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Amicus Therapeutics Full Year 2024 Financial Results Conference Call and Webcast.
Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
Billionaire Hedge Funds
